Soukaina Amniouel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Soukaina Amniouel has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Ewy A. Mathé
National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publication- Keertana Yalamanchili
Cardiovascular Research Center, Department of Surgery, Rhode Island Hospital, Providence, RI 02903, USA
1 shared publication - Mohsin Saleet Jafri
School of Systems Biology, George Mason University, Fairfax, VA 22030, USA
1 shared publication - Sreenidhi Sankararaman
School of System Biology, George Mason University, Fairfax, VA 22030, USA
1 shared publication - Wei Zheng
National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA
1 shared publication - Zeenat Asghar
National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by Elsevier in Drug Discovery Today
- Vol. 31 (6) , 104836
AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases
- 16 October 2026
- Published by Elsevier in Drug Discovery Today
- Vol. 31 (6) , 104836
Open AccessAI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases
- Open Access
- 22 May 2024
- Published by MDPI AG in BioMedInformatics
- Vol. 4 (2) , 1396-1424
Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine Learning
Background: Ovarian cancer (OC) is the most lethal gynecological cancer in the United States. Among the different types of OC, serous ovarian cancer (SOC) stands out as the most prevalent. Transcriptomics techniques generate extensive gene expression data, yet only a few of these genes are relevant to clinical diagnosis. Methods: Methods for feature selection (FS) address the challenges of high dimensionality in extensive datasets. This study proposes a computational framework that applies FS techniques to identify genes highly associated with platinum-based chemotherapy response on SOC patients. Using SOC datasets from the Gene Expression Omnibus (GEO) database, LASSO and varSelRF FS methods were employed. Machine learning classification algorithms such as random forest (RF) and support vector machine (SVM) were also used to evaluate the performance of the models. Results: The proposed framework has identified biomarkers panels with 9 and 10 genes that are highly correlated with platinum–paclitaxel and platinum-only response in SOC patients, respectively. The predictive models have been trained using the identified gene signatures and accuracy of above 90% was achieved. Conclusions: In this study, we propose that applying multiple feature selection methods not only effectively reduces the number of identified biomarkers, enhancing their biological relevance, but also corroborates the efficacy of drug response prediction models in cancer treatment.
- 22 May 2024
- Published by MDPI AG in BioMedInformatics
- Vol. 4 (2) , 1396-1424
Open AccessEvaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine Learning
Background: Ovarian cancer (OC) is the most lethal gynecological cancer in the United States. Among the different types of OC, serous ovarian cancer (SOC) stands out as the most prevalent. Transcriptomics techniques generate extensive gene expression data, yet only a few of these genes are relevant to clinical diagnosis. Methods: Methods for feature selection (FS) address the challenges of high dimensionality in extensive datasets. This study proposes a computational framework that applies FS techniques to identify genes highly associated with platinum-based chemotherapy response on SOC patients. Using SOC datasets from the Gene Expression Omnibus (GEO) database, LASSO and varSelRF FS methods were employed. Machine learning classification algorithms such as random forest (RF) and support vector machine (SVM) were also used to evaluate the performance of the models. Results: The proposed framework has identified biomarkers panels with 9 and 10 genes that are highly correlated with platinum–paclitaxel and platinum-only response in SOC patients, respectively. The predictive models have been trained using the identified gene signatures and accuracy of above 90% was achieved. Conclusions: In this study, we propose that applying multiple feature selection methods not only effectively reduces the number of identified biomarkers, enhancing their biological relevance, but also corroborates the efficacy of drug response prediction models in cancer treatment.